Description
Framed around the idea that how countries spend is as important as what
countries spend, this presentation provides some background on the mis-match between the global
burden of cancer and other NCDs and the level of investment they receive. It highlights the importance of evidence-based and cost-effective
investments in cancer, introducing the suite of recommended interventions for
cancer prevention, diagnosis, treatment, and care as a way of making the most
effective use of limited resources for cancer care.
Click on the Resources tab above to access additional information, resources and reports on those topics.
Contributors
-
Rachel Nugent
Dr. Rachel Nugent retired in 2023 as Director of the Center for Global Noncommunicable Diseases (NCDs) at RTI International. She is now a Senior Technical Advisor for the Center. She has more than 30 years of experience in global development as a researcher, practitioner, and policy advisor to governments. Dr. Nugent led the Lancet Task Force on NCDs and Economics in 2018. She is currently a member of the Lancet Commission on Women and Cancer, the Food System Economics Commission, and the Advisory Group of the Center for Health Incentives and Behavioral Economics at the University of Pennsylvania. She also works with the World Health Organization Global Coordination Mechanism Working Group on NCD Financing and NCD Implementation Research. Dr. Nugent is an affiliate associate professor at the University of Washington's Department of Global Health. She formerly served as a member of the U.S. Institute of Medicine Committee on Economic Evaluation, the International Expert Group for the Global Nutrition Report, and the External Advisory Committee of the NCD Alliance and Children’s Heartlink. Before RTI, Dr. Nugent worked at the Center for Global Development, the Population Reference Bureau, the Fogarty International Center of NIH, and the Food and Agriculture Organization of the United Nations.